Loading provider…
Loading provider…
Hematology & Oncology Physician in Boston, MA
NPI: 1043303688Primary Practice Location
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston, MA
Primary Employer
Massachusetts General Hospital
massgeneral.org
HQ Phone
Get M.D. Revati's Phone NumberMobile
Get M.D. Revati's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 134 | 312 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 79 | 334 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 23 | 23 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 22 | 27 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 16 | 46 |
Lead Sponsor: Massachusetts General Hospital
Collaborators: National Comprehensive Cancer Network
Intervention / Treatment: OTHER: Usual Care, BEHAVIORAL: Supportive Care Mobile Application
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, PROCEDURE: Computed Tomography, PROCEDURE: Echocardiography Test, OTHER: Observation Activity
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Clinical Observation, OTHER: Placebo Administration, DRUG: Erlotinib Hydrochloride